Researchers noted reduced food intake in the highest dose group. Females in this group exhibited increased plasma cholesterol concentrations at 13 and 26 weeks. Both males and females in this group exhibited increased cytochrome P450 activity in the liver and increases in liver weights at the end of the study. No adverse effects were observed at the two lowest doses.